Effects of cytokines on matrix metalloproteinase expression in oral squamous cell carcinoma in vitro

Acta Oto-Laryngologica

Volumn 125, Issue 7, 2005, Pages 765-773

  Sundelin, Kaarina ^a   Roberg, Karin ^a   Grénman, Reidar ^b   Håkansson, Leif ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cytokine; Matrix metalloproteinase; Oral cancer; Squamous cell carcinoma

Indexed keywords

CYTOKINE; GELATINASE A; GELATINASE B; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; UPREGULATION; ZYMOGRAPHY;

CARCINOMA, SQUAMOUS CELL; CELL LINE; CELL LINE, TUMOR; CYTOKINES; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-6; MATRIX METALLOPROTEINASES; MOUTH NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 22944454497     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480510027484     Document Type: Article

References (35)

1. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003;200:448-64.
2. Molina MA, Codony-Servat J, Albanell J, Rojo F, Arribas J, Baselga J. Trastuzumab (herceptin), a humanized anti-HER2 receptor monoclonal antibody, inhibits basal and activated HER2 ectodomain cleavage in breast cancer cells. Cancer Res 2001;61:4744-9.
3. Williams LM, Gibbons DL, Gearing A, Maini RN, Feldmann M, Brennan FM. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures. J Clin Invest 1996;97:2833-41.
4. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995;154:4379-89.
5. Sutinen M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, et al. Expression of matrix metalloproteinases (MMP-1 and MMP-2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer 1998;77:2239-45.
6. Imanishi Y, Fujii M, Tokumaru Y, Tomita T, Kanke M, Kanzaki J, et al. Clinical significance of expression of membrane type 1 matrix metalloproteinase and metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum Pathol 2000;31:895-904.
7. Nagata M, Fujita H, Ida H, Hoshina H, Inoue T, Seki Y, et al. Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer 2003;106:683-9.
8. Yoshizaki T, Maruyama Y, Sato H, Furukawa M. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int J Cancer 2001;95:44-50.
9. Ondruschka C, Buhtz P, Motsch C, Freigang B, Schneider-Stock R, Roessner A, et al. Prognostic value of MMP-2, -9, and TIMP-1, -2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas. Pathol Res Pract 2002;198:509-15.
10. Yorioka CW, Coletta RD, Alves F, Nishimoto IN, Kowalski LP, Graner E. Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients. Int J Oncol 2002;20:189-94.
11. O-Charoenrat P, Rhys-Evans PH, Eccles SA. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2001;127:813-20.
12. Dünne AA, Sesterhenn A, Gerisch A, Teymoortash A, Kuropkat C, Werner JA. Expression of MMP-2, -9 and -13 in cell lines and fresh biopsies of squamous cell carcinomas of upper aerodigestive tract. Anticancer Res 2003;23:2233-40.
13. Riedel F, Götte K, Schwalb J, Bergler W, Hörmann K. Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma. Int J Oncol 2000;17:1099-105.
14. O-charoenrat P, Rhys-Evans P, Court WJ, Box GM, Eccles SA. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands. Clin Exp Metastasis 1999;17:631-9.
15. Feliciani C, Gupta AK, Sauder DN. Keratinocytes and cytokine/growth factors. Crit Rev Oral Biol Med 1996;7:300-18.
16. Watanabe H, Iwase M, Ohashi M, Nagumo M. Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines. Oral Oncol 2002;38:670-9.
17. Hasina R, Matsumoto K, Matsumoto-Taniura N, Kato I, Sakuda M, Nakamura T. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line. Br J Cancer 1999;80:1708-17.
18. Woods KV, El-Naggar A, Clayman GL, Grimm EA. Variable expression of cytokines in human head and neck squamous cell carcinoma lines and consistent expression in surgical specimens. Cancer Res 1998;58:3132-41.
19. Hanzawa M, Shindoh M, Higashino F, Yasuda M, Inoue N, Hida K, et al. Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 2000;21:1079-85.
20. Irwin CR, Myrillas TT, Traynor P, Leadbetter N, Cawston TE. The role of soluble interleukin (IL)-6 receptor in mediating the effects of IL-6 on matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression by gingival fibroblasts. J Periodontol 2002;73:741-7.
21. Mann EA, Hibbs MS, Spiro JD, Bowik C, Wang XZ, Clawson M, et al. Cytokine regulation of gelatinase production by head and neck squamous cell carcinoma: the role of tumour necrosis factor-alpha. Ann Otol Rhinol Laryngol 1995;104:203-9.
22. Lansford CD, Grénman R, Bier H, Somers KD, Kim S-Y, Whiteside TL, et al. Head and neck cancers In: Masters J, Palsson B, editors. Human cell culture, Vol. 2, Cancer cell lines, Part 2. Dordrecht, The Netherlands: Kluwer Academic Press; 1999. p. 185-255.
23. Pekkola-Heino K, Servomaa K, Kiuru A, Grénman R. Increased radiosensitivity is associated with p53 mutations in cell lines derived from oral cavity carcinoma. Acta Otolaryngol (Stockh) 1996;116:341-4.
24. Hauser U, Balz V, Carey TE, Grénman R, van Lierop A, Scheckenbach K, et al. Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region. Head Neck 2002;24:868-73.
25. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002;295:2387-92.
26. Sottrup-Jensen L. α-Macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem 1989;264:11539-42.
27. Leicht M, Briest W, Hölzl A, Zimmer H-G. Serum depletion induces cell loss of rat cardiac fibroblasts and increased expression of extracellular matrix proteins in surviving cells. Cardiovasc Res 2001;52:429-37.
28. Liao J, Wolfman JC, Wolfman A. K-Ras regulates the steady-state expression of matrix metalloproteinase 2 in fibroblasts. J Biol Chem 2003;278:31871-8.
29. Taga T, Hibi M, Hirata K, Yamasaki K, Yasukawa K, Matsuda T, et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp 130. Cell 1989;58:573-81.
30. + cells. J Exp Med 1996;183:837-45.
31. Barillé S, Collette M, Thabard W, Bleunven C, Bataille R, Amiot M. Soluble IL-6Rα upregulated IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells. Cytokine 2000;12:1426-9.
32. To Y, Dohi M, Matsumoto K, Tanaka R, Sato A, Nakagome K, et al. A two-way interaction between hepatocyte growth factor and interleukin-6 in tissue invasion of lung cancer cell line. Am J Respir Cell Mol Biol 2002;27:220-6.
33. Rosenthal EL, Johnson TM, Allen ED, Apel IJ, Punturieri A, Weiss SJ. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells. Cancer Res 1998;58:5221-30.
34. Bennett JH, Morgan MJ, Whawell SA, Atkin P, Roblin P, Furness J, et al. Metalloproteinase expression in normal and malignant oral keratinocytes: stimulation of MMP-2 and MMP-9 by scatter factor. Eur J Oral Sci 2000;108:281-91.
35. Johansson N, Ala-aho R, Uitto V, Grénman R, Fusenig NE, López-Otín C, et al. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J Cell Sci 2000;113:227-35.